Table 2.
Demographic and clinical characteristics of the Brugada patients with CRP < or ≥ 2 mg/l.
| CRP < 2 mg/L (n = 28) | CRP ≥ 2 mg/L (n = 26) | P value | 95%CI | ||
|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | ||||
| Age (years) | 44 ± 14 | 46 ± 12 | ns | — | |
| Male | 24 (86%) | 25 (96%) | ns | — | |
| Coved-type ECG | 13 (46%) | 20 (77%) | .022 | ns | |
| VT/FV | 1 (4%) | 4 (15%) | ns | — | |
| Family history | 5 (18%) | 10 (38%) | ns | — | |
| Syncope | 5 (18%) | 12 (46%) | .025 | ns | |
| Aborted SCA | 0 | 3 (12%) | ns | ||
| Overall symptoms (syncope and/or aborted SCA) | 5 (18%) | 15 (58%) | .018 | 0.039 | 1.07–18.79 |
| ICD† | 8 (29%) | 18 (69%) | .003 | ns | |
CRP: C-reactive protein; VT: ventricular tachycardia; FV: ventricular fibrillation; SCD: sudden cardiac death; ICD: implantable cardioverter-defibrillator; †placement of ICD was done before (>3 months) or after blood testing for serum CRP concentration.